Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation for Patients With Asymptomatic CNS Metastatic Disease

NCT02866981 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT02866981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation for Patients With Asymptomatic CNS Metastatic Disease
Lead sponsor
The Cooper Health System
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
December 1, 2017
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic cancer